10 Dividend Stocks That Yield 3% or More
As most advisors are well aware, high stock prices have pushed down the market’s dividend yield. Barron’s ran a screen for ...
manilatimes9d
Body Contouring Treatments Market to Hit USD 2.58 Billion by 2029 with 10.0% CAGR | MarketsandMarkets™
The global body contouring treatments market growth forecasted to transform from USD 1.46 billion in 2024 to USD 2.58 billion ...
Nasdaq14d
Is AbbVie (NYSE:ABBV) Stock a Buy After Its Dividend Hike?
Pharmaceutical company AbbVie (ABBV) is the latest stock in my portfolio to announce a higher dividend. Accompanying its third-quarter earnings report, AbbVie declared a 5.8% increase in its ...
Zacks.com on MSN14d
5 Stocks That Recently Announced Dividend Hikes
The U.S. macroeconomic environment remains favorable for investors. Current interest rates are in the range of 4.75-5.00% ...
WBEZ15d
New Chicago School Board president apologizes for social media posts criticized as antisemitic
The Rev. Mitchell Ikenna Johnson says he won’t resign, despite calls from 26 City Council members and other leaders. The ...
Morningstar16d
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
NORTH CHICAGO, Ill. and BRANFORD, Conn., Oct. 31, 2024 (GLOBE NEWSWIRE) -- AbbVie (NYSE: ABBV) and EvolveImmune Therapeutics, an immuno-oncology company developing next-generation biotherapeutics ...
Reuters16d
AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq
Oct 30 (Reuters) - AbbVie (ABBV.N), opens new tab raised its annual profit forecast after strong sales of its newer immunology drugs and key cancer treatment helped the company beat Wall Street ...
BioWorld18d
Abbvie snags Alzheimer’s candidate in $1.4B Aliada buyout
Only three years after it was co-founded by Johnson & Johnson, Aliada Therapeutics Inc. is being acquired by Abbvie Inc. in a deal valued at $1.4 billion that gives the big pharma firm another shot at ...
Reuters18d
AbbVie banks on Alzheimer's therapy with $1.4 billion buy of Aliada
October 28, 202410:12 PM UTCUpdated ago Oct 28 (Reuters) - U.S. drugmaker AbbVie (ABBV.N), opens new tab said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an ...
Ad Age19d
AbbVie—ad spending, facts and profile
Are you a print subscriber? Activate your account. By Adrianne Pasquarelli - 2 hours 3 min ago By Erika Wheless - 2 hours 3 min ago By Brian Bonilla - 2 hours 3 min ago By Tim Nudd - 2 hours 3 min ...
NDTV20d
"Could Have Inflicted Much More Damage": Israel Envoy To NDTV After Iran Strikes
Israel wants peace in the region but is not ready to be attacked by Iran directly or indirectly, the country's Ambassador to India, Reuven Azar, has said. Speaking exclusively to NDTV on Saturday ...
CBS News20d
Israel, Iran urged to use restraint by world leaders, amid concerns of a regional war
Israel's pre-dawn airstrikes on military targets in Iran in retaliation for the barrage of ballistic missiles the Islamic republic fired on Israel earlier this month were met with mixed reactions ...